2026 NPPES data Otolaryngology Physician NPI 1770571721 M.D.
Verify on CMS →

SCOTT HARDEMAN, M.D.

Otolaryngology Physician in SAINT LOUIS, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 449 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

SCOTT HARDEMAN, M.D. filed 1,222 Medicare Part D claims in 2023 as a Otolaryngology Physician in SAINT LOUIS, Missouri, prescribing 98% generic.

1K
Part D claims, 2023
98%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SCOTT HARDEMAN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,222 Top 22% higher than 78% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). This entry sits in this band. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

SCOTT HARDEMAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SCOTT HARDEMAN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 10/12/2005

NPI 1770571721

Primary specialty

Otolaryngology Physician

Mid-sized

10,895 US NPIs in this specialty

Medicare Part D claims

1,222 140% vs specialty avg

2023 prescription claims

Specialty avg: 509

Specialty distribution in Missouri

How Otolaryngology Physician compares to other specialties among Missouri providers

Missouri providers

Otolaryngology Physician share within Missouri

1. Otolaryngology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology Physician share within Missouri

Specialty board-certification context

Estimated specialty board-certified rate — Otolaryngology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Otolaryngology Physician ABMS/AOA estimate

Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SCOTT HARDEMAN, M.D. appears in the CMS NPPES registry as a Otolaryngology Physician provider holding M.D. credentials at 9701 LANDMARK PARKWAY DR, SAINT LOUIS, MO, 63127, with a listed phone of (314) 843-3828. NPI 1770571721 was issued on 10/12/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HARDEMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,222 prescription claims written by this provider, covering 449 Medicare beneficiaries and totaling roughly $34K in drug spend, split 2% brand-name and 98% generic by claim count, with an opioid prescribing rate of 2.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

9701 LANDMARK PARKWAY DR
SAINT LOUIS, MO 63127

Provider Details

NPI 1770571721
Specialty Otolaryngology Physician
Credentials M.D.
Gender Male
NPI Issued 10/12/2005

Hospital and facility affiliations

Facilities where SCOTT HARDEMAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MERCY HOSPITAL PERRY
★★☆☆☆ 2/5
PERRYVILLE, MO
Critical Access Hospitals
CMS CCN: 261311
GWENT LLC
SAINT LOUIS, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Generic-heavy

SCOTT HARDEMAN, M.D. — brand share 2.0%
Specialty average (est.)

2% brand-name claims vs 98% generic, on 1,222 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,222
Total Claims
$34K
Total Drug Cost
449
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,772
Total Day Supply
45,566
Brand vs Generic
2% brand / 98% generic
Brand Drug Cost
$4K
Generic Drug Cost
$30K
Opioid Claims
31 (2.5% rate)
Antibiotic Claims
105

Patient Demographics

Average Patient Age
73.7 years
Avg HCC Risk Score
1.15
Gender Split
64% female / 36% male
Age Distribution
<65: 29, 65-74: 233, 75-84: 143, 85+: 44

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SCOTT HARDEMAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Azelastine Hcl
228
Fluticasone Propionate
148
Ipratropium Bromide
145
Pantoprazole Sodium
138
Fluocinolone Acetonide Oil
95
Prednisone
65
Mupirocin
56
Omeprazole
42
Cefdinir
38
Ofloxacin
34

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology Physician Overview

How SCOTT HARDEMAN, M.D. fits within the Otolaryngology Physician landscape nationally.

10,895
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider

SCOTT HARDEMAN, M.D.'s 1,222 claims are above the specialty average of 509.

Nearby Otolaryngology Physician Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as HARDEMAN.

Compare Otolaryngology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SCOTT HARDEMAN, M.D.'s specialty?
SCOTT HARDEMAN, M.D. specializes in Otolaryngology Physician and practices in SAINT LOUIS, Missouri. Credentials: M.D..
How much does SCOTT HARDEMAN, M.D. prescribe under Medicare Part D?
In 2023, SCOTT HARDEMAN, M.D. wrote 1,222 Medicare Part D claims totaling $34K in drug costs for 449 beneficiaries.
Where is SCOTT HARDEMAN, M.D. located?
SCOTT HARDEMAN, M.D. is located at 9701 LANDMARK PARKWAY DR, SAINT LOUIS, MO, 63127. Phone: (314) 843-3828.
What is SCOTT HARDEMAN, M.D.'s NPI number?
SCOTT HARDEMAN, M.D.'s National Provider Identifier (NPI) is 1770571721, issued on 10/12/2005.
Does SCOTT HARDEMAN, M.D. prescribe more brand-name or generic drugs?
SCOTT HARDEMAN, M.D.'s prescribing is 2% brand-name and 98% generic drugs by claim count, with $4K in brand drug costs.
Does SCOTT HARDEMAN, M.D. prescribe opioids?
Yes, SCOTT HARDEMAN, M.D. had 31 opioid claims in 2023 with an opioid prescribing rate of 2.5%.
How many Otolaryngology Physician providers are there in the US?
There are 10,895 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does SCOTT HARDEMAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SCOTT HARDEMAN, M.D.'s most frequently prescribed drugs include Azelastine Hcl, Fluticasone Propionate, Ipratropium Bromide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SCOTT HARDEMAN, M.D. accept Medicare?
SCOTT HARDEMAN, M.D. appears in CMS Medicare data with 1,222 Part D claims and 449 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SCOTT HARDEMAN, M.D.'s credentials?
SCOTT HARDEMAN, M.D.'s NPI is 1770571721 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology